GARDASIL SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Merck Sharp & Dohme B.V

Manufacturer · Finished Dosage FormsNetherlands

Basic Information

1

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Injectables & Parenterals / Small Volume Parenterals (SVP)

Trade Type

Sell

Product Name

GARDASIL SUSPENSION INYECTABLE EN JERINGA PRECARGADA

Details

VIRUS PAPILOMA HUMANO TIPO 6 PROTEINA L1 20 µg • VIRUS PAPILOMA HUMANO TIPO 11 PROTEINA L1 40 µg • VIRUS PAPILOMA HUMANO TIPO 16 PROTEINA L1 40 µg • VIRUS PAPILOMA HUMANO TIPO 18 PROTEINA L1 20 µg

Substance

VIRUS PAPILOMA HUMANO TIPO 6 PROTEINA L1 • VIRUS PAPILOMA HUMANO TIPO 11 PROTEINA L1 • VIRUS PAPILOMA HUMANO TIPO 16 PROTEINA L1 • VIRUS PAPILOMA HUMANO TIPO 18 PROTEINA L1

Registered Market

Spain

Distributor(s)

Merck Sharp & Dohme De Espana S.A. - Spain.

Specifications

Dosage Form: Injectable suspension
ATC Code: J07BM01
Packaging: GARDASIL suspension injectable in pre-filled syringe, 1 pre-filled syringe of 0,5 ml + 2 needles

Documents

Drug Marketing Authorization Number

Document No.: 06357007

Issue Date: May 6, 2007

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product